Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05082623
Other study ID # Music in intensive care
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 14, 2020
Est. completion date October 2021

Study information

Verified date October 2021
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the effect of a twice daily, 60-minute, nurse initiated, music listening intervention on patients followed in the ICU with MV support as compared to patients who receive care as usual and ear plugs.


Description:

Delirium is an acute disorder of consciousness and cognitive function that occurs frequently in critical care settings. Many critically ill patients (e.g., up to 80% of patients) experience ICU delirium due to underlying medical or surgical health problems, recent surgical or other invasive procedures, medications, or various noxious stimuli (e.g., underlying psychological stressors, mechanical ventilation [MV], noise, light, patient care interactions, and drug-induced sleep disruption or deprivation). Delirium contributes to adverse outcomes such as increased mortality and morbidity, longer length of ICU stays, prolonged MV, costlier hospitalizations, and cognitive impairment after hospital discharge. The Society of Critical Care Medicine (SCMM) Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) recommend non-pharmacological interventions of preventing delirium and other symptoms. Music, which is one of the non-pharmacological applications, is one of the cognitive-behavioral treatment methods applied in the field of ICU as in many other fields. Music is easy method to apply and has no side effects and contributes to physical, psychological, emotional and spiritual healing. In the literature, it is seen that music intervention studies applied to patients followed in the ICU mostly focus on the effects on anxiety, pain, non-invasive ventilation tolerance, and stress response (heart rate, blood pressure, respiratory rate). The relationship between intensive care delirium and all these symptoms (pain, agitation, anxiety, stress response, etc.) and their interaction with each other have been clarified in the light of evidence-based guidelines and studies. Therefore, the aim of this study is to examine the effects of music applied to patients followed in the ICU with MV support on delirium, pain, need for sedation, anxiety and vital parameters.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 37
Est. completion date October 2021
Est. primary completion date September 14, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - =18 years, - Admitted to the ICU as of the start of the study and planned to be followed up in the ICU for at least 24 hours, - Needing invasive MV for at least 24 hours, - Pre-deliric score > 20% - At least one positive delirium according to CAM-ICU, - GCS score > 8, - RASS score = -3, - Hemodynamically stable, - CPOT score = 3 Exclusion Criteria: - Hearing or vision problems, - Diagnosed with psychiatric illness, - Diagnosed with dementia, - Having acute neurological injury, - Alcohol/drug poisoning - Hemodynamically unstable and treated with high-dose inotropic/vasopressor medication, - Pregnant, - Planned to be followed in ICU for less than 24 hours, - Does not need MV, - GCS score = 8, - RASS score < -3, - Patients referred from another ICU

Study Design


Intervention

Other:
Music
Music medicine
Earplug
Earplug with noise cancelling

Locations

Country Name City State
Turkey Ege University Izmir

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Length of ICU stay The total days of ICU stay. During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
Other Duration of mechanical ventilation The total days of mechanical ventilation. During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
Other Delirium duration The delirium duration will be calculated when the patient is first considered to have delirium to the last time that patient is not supposed to have delirium based on CAM-ICU. During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
Primary Delirium The delirium event assessed twice daily by trained research nurse using the CAM-ICU. The diagnosis of delirium is based on the presence of two major criteria (i.e. acute or fluctuating onset plus lack of attention) and at least one of the minor criteria (disorganized thinking or altered consciousness level). Date of study enrollment through 12 months.
Secondary Delirium severity In case of positive delirium, its severity assessed twice daily by trained research nurse using the CAM-ICU-7. CAM-ICU-7 is a seven point scale (0-7), derived from the RASS and the CAM-ICU. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Pain severity Pain assessed by trained research nurse utilizing the Critical Care Pain Observation Tool (CPOT) a valid and reliable instrument in critically ill patients with and without delirium. The CPOT has 4 components: facial expression, body movements, muscle tension, and compliance with the ventilator for intubated patients or vocalization for extubated patients. Each component is scored from 0 to 2 with a possible total score ranging from 0 to 8. A CPOT = 3 is indicative of significant pain. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Need of sedation Sedation level assessed by trained research nurse using the Richmond Agitation-Sedation Scale (RASS). It is a ranking scale with 10-level (+4 "combative" to -5 "unarousable") used to measure the agitation or sedation level of a person. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Anxiety level Anxiety level assessed by trained research nurse using Face Anxiety Scale. The scale is composed of five face types. The face type in the left-hand corner indicates an absence of anxiety, while anxiety increases towards the faces in the right-hand corner. When patient scores were three or above, their anxiety was determined to be medium to high. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Systolic/diastolic blood pressure Changes in the systolic/diastolic blood pressure (mm/Hg). Blood pressure was recorded from monitor of patient. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Heart rate Changes in the heart rate. Heart rate was measured as number of heartbeats in a per minute from monitor of patient. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Respiratory rate Changes in the respiratory rate. Respiratory rate was measured as number of breaths in a per minute from monitor of patient. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Secondary Oxygen saturation Changes in the oxygen saturation. Saturation was recorded from monitor of patient. 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care